Abbott: Migraine Disorders trials

The registry lists 10 Migraine Disorders studies with Abbott as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 2 2Phase 3 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Peripheral Nerve Stimulation Registry for Intractable Migraine HeadacheCompletedNCT02227758Results posted
• IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical PracticeCompletedNCT02115269Results posted
• PREMIUM Migraine TrialCompletedNCT00355056Not applicableResults posted
• PRIMA PFO Migraine TrialTerminatedNCT00505570Phase 2
• STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?TerminatedNCT00369499Not applicable
• ESCAPE Migraine TrialTerminatedNCT00267371Phase 3
• Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With MigraineCompletedNCT00195806Phase 3
• A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.CompletedNCT00195754Phase 3
• The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in AdolescentsCompletedNCT00195741Phase 3
• Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine HeadacheCompletedNCT00123201Phase 2